| | |
Excess P&I mortality rate per 100,000 population
|
|---|
|
Lag 0
|
Lag 1
|
Lag 2
|
|---|
|
ER
|
95% CI
|
ER
|
95% CI
|
ER
|
95% CI
|
|---|
|
Proxy: positive number
|
| |
A (H1N1)
|
0.14
|
(0.06, 0.22)
|
0.16
|
(0.09, 0.24)
|
0.14
|
(0.08, 0.22)
|
| |
A (H3N2)
|
0.09
|
(−0.02, 0.20)
|
0.17
|
(0.07, 0.28)
|
0.21
|
(0.10, 0.31)
|
| |
B (Victoria)
|
−0.08
|
(−0.19, 0.04)
|
−0.07
|
(−0.19, 0.03)
|
−0.05
|
(−0.16, 0.05)
|
| |
B (Yamagata)
|
0.06
|
(−0.03, 0.14)
|
0.09
|
(0.00, 0.17)
|
0.12
|
(0.04, 0.20)
|
| |
Influenza
|
0.20
|
(−0.02, 0.41)
|
0.34
|
(0.12, 0.53)
|
0.41
|
(0.23, 0.59)
|
|
Proxy: positive proportion
|
| |
A (H1N1)
|
0.18
|
(0.09, 0.26)
|
0.19
|
(0.11, 0.27)
|
0.18
|
(0.10, 0.25)
|
| |
A (H3N2)
|
0.13
|
(0.00, 0.27)
|
0.21
|
(0.08, 0.33)
|
0.25
|
(0.13, 0.36)
|
| |
B (Victoria)
|
−0.01
|
(−0.15, 0.11)
|
−0.03
|
(−0.16, 0.08)
|
−0.08
|
(−0.20, 0.04)
|
| |
B (Yamagata)
|
0.11
|
(0.01, 0.23)
|
0.12
|
(0.02, 0.22)
|
0.16
|
(0.06, 0.25)
|
| |
Influenza
|
0.40
|
(0.12, 0.67)
|
0.48
|
(0.24, 0.71)
|
0.50
|
(0.27, 0.70)
|
|
Proxy: LAB × ILI
|
| |
A (H1N1)
|
0.13
|
(0.06, 0.19)
|
0.12
|
(0.06, 0.18)
|
0.11
|
(0.05, 0.17)
|
| |
A (H3N2)
|
0.13
|
(0.03, 0.23)
|
0.19
|
(0.09, 0.28)
|
0.21
|
(0.12, 0.30)
|
| |
B (Victoria)
|
−0.03
|
(−0.13, 0.06)
|
−0.06
|
(−0.15, 0.04)
|
−0.10
|
(−0.20, −0.01)
|
| |
B (Yamagata)
|
0.10
|
(0.01, 0.19)
|
0.11
|
(0.02, 0.20)
|
0.14
|
(0.05, 0.22)
|
| |
Influenza
|
0.31
|
(0.12, 0.51)
|
0.36
|
(0.17, 0.53)
|
0.35
|
(0.19, 0.51)
|
-
P&I pneumonia and influenza, ER excess rate, LAB × ILI product of weekly proportion of specimens tested positive for influenza and influenza-like illness consultation rate, CI confidence interval
